ST
BMRN icon

Spot Trading’s BioMarin Pharmaceuticals BMRN Stock Holding History

Spot Trading’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$2.38M Sell
25,600
-3,300
-11% -$292K 0.04% 632
2017
Q2 		$2.63M Buy
28,900
+26,200
+970% +$2.38M 0.05% 513
2017
Q1 		$237K Sell
2,700
-7,400
-73% -$658K 0.01% 1800
2016
Q4 		$837K Sell
10,100
-22,600
-69% -$1.94M 0.02% 1069
2016
Q3 		$3.02M Sell
32,700
-12,300
-27% -$1.16M 0.06% 466
2016
Q2 		$3.5M Buy
45,000
+32,500
+260% +$2.76M 0.06% 434
2016
Q1 		$1.03M Hold
12,500
– – 0.02% 1084
2015
Q4 		$1.31M Sell
12,500
-9,400
-43% -$982K 0.01% 1277
2015
Q3 		$2.31M Buy
21,900
+21,800
+21,800% +$2.91M 0.02% 988
2015
Q2 		$14K Sell
100
-8,900
-99% -$1.1M ﹤0.01% 3512
2015
Q1 		$1.12M Sell
9,000
-23,400
-72% -$2.48M 0.01% 1504
2014
Q4 		$2.93M Buy
32,400
+23,800
+277% +$1.98M 0.02% 1142
2014
Q3 		$621K Sell
8,600
-5,100
-37% -$335K ﹤0.01% 2409
2014
Q2 		$852K Sell
13,700
-300
-2% -$18.1K ﹤0.01% 2258
2014
Q1 		$955K Sell
14,000
-700
-5% -$51.6K 0.01% 2059
2013
Q4 		$1.03M Sell
14,700
-95,300
-87% -$6.47M 0.01% 1952
2013
Q3 		$7.94M Buy
110,000
+82,100
+294% +$5.46M 0.05% 476
2013
Q2 		$1.55M Buy
+27,900
New +$1.74M 0.01% 1580

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Spot Trading's BMRN Position: Q3 2017 in Review

Spot Trading increased its BioMarin Pharmaceuticals (BMRN) stake by 342% in Q3 2017, buying an estimated $585K and bringing the position to 8,551 shares worth $796K. The position accounts for 0.01% of the portfolio, ranked #1317.

Spot Trading first reported a position in BMRN in Q2 2013 and has held it in 17 quarters since. The position peaked at $2.49M in Q2 2016. 411 funds tracked by Wall St. Rank hold BMRN as of Q3 2017.

  • Spot Trading held 8,551 shares of BioMarin Pharmaceuticals worth $796K as of Q3 2017.
  • Spot Trading bought 6,616 BioMarin Pharmaceuticals shares in Q3 2017, an estimated $585K.
  • BioMarin Pharmaceuticals made up 0.01% of Spot Trading's portfolio in Q3 2017, its #1317 holding.
  • Spot Trading first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 17 quarters since.
  • Spot Trading's BioMarin Pharmaceuticals position peaked at $2.49M in Q2 2016.
  • 411 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.